Literature DB >> 16857275

Antiviral acyclic nucleoside phosphonates structure activity studies.

Antonín Holý1.   

Abstract

This review concerns acyclic nucleoside phosphonates (ANP) and describes the concept of the design of isopolar and isosteric nucleotide analogues resistant towards degradation by enzymes in vivo. It describes the development of research which led to the discovery of several structurally related potent antivirals and ultimately resulted in the development of drugs directed against HIV, HBV and DNA-virus infections in general, namely adefovir, cidofovir and tenofovir. In addition to these "classical compounds" the review describes the present development in the field of ANP, the "open-ring ANP" and discusses the present achievements, concept of prodrug design and application.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857275     DOI: 10.1016/j.antiviral.2006.06.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

1.  Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy.

Authors:  M S Palombo; Y Singh; P J Sinko
Journal:  J Drug Deliv Sci Technol       Date:  2009       Impact factor: 3.981

2.  Amidate Prodrugs of O-2-Alkylated Pyrimidine Acyclic Nucleosides Display Potent Anti-Herpesvirus Activity.

Authors:  Min Luo; Elisabetta Groaz; Robert Snoeck; Graciela Andrei; Piet Herdewijn
Journal:  ACS Med Chem Lett       Date:  2020-06-24       Impact factor: 4.345

Review 3.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 4.  Flexibility-Not just for yoga anymore!

Authors:  Katherine Seley-Radtke
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

Review 5.  The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold.

Authors:  Katherine L Seley-Radtke; Mary K Yates
Journal:  Antiviral Res       Date:  2018-04-10       Impact factor: 10.103

6.  A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy.

Authors:  Nicola L Ramsden; Lori Buetow; Alice Dawson; Lauris A Kemp; Venkatsubramanian Ulaganathan; Ruth Brenk; Gerhard Klebe; William N Hunter
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

7.  Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.

Authors:  Roberto Romeo; Daniela Iannazzo; Lucia Veltri; Bartolo Gabriele; Beatrice Macchi; Caterina Frezza; Francesca Marino-Merlo; Salvatore V Giofrè
Journal:  Molecules       Date:  2019-05-02       Impact factor: 4.411

Review 8.  Remdesivir against COVID-19 and Other Viral Diseases.

Authors:  Jakob J Malin; Isabelle Suárez; Vanessa Priesner; Gerd Fätkenheuer; Jan Rybniker
Journal:  Clin Microbiol Rev       Date:  2020-10-14       Impact factor: 26.132

Review 9.  Synthetic Life with Alternative Nucleic Acids as Genetic Materials.

Authors:  Peng Nie; Yanfen Bai; Hui Mei
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.